alprazolam xr

Generic: alprazolam

Labeler: mylan pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name alprazolam xr
Generic Name alprazolam
Labeler mylan pharmaceuticals inc.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

alprazolam .5 mg/1

Manufacturer
Mylan Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 59762-0057
Product ID 59762-0057_70f0098e-50b5-4e61-b4e0-141a55d92267
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA021434
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2003-01-17

Pharmacologic Class

Established (EPC)
benzodiazepine [epc]
Chemical Structure
benzodiazepines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 597620057
Hyphenated Format 59762-0057

Supplemental Identifiers

RxCUI
433798 433799 433800 433801
UNII
YU55MQ3IZY
NUI
N0000175694 M0002356

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name alprazolam xr (source: ndc)
Generic Name alprazolam (source: ndc)
Application Number NDA021434 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • .5 mg/1
source: ndc
Packaging
  • 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (59762-0057-1)
source: ndc

Packages (1)

59762-0057-1 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (59762-0057-1)

Ingredients (1)

alprazolam (.5 mg/1)

Linked Drug Pages (1)

Alprazolam XR ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "70f0098e-50b5-4e61-b4e0-141a55d92267", "openfda": {"nui": ["N0000175694", "M0002356"], "unii": ["YU55MQ3IZY"], "rxcui": ["433798", "433799", "433800", "433801"], "spl_set_id": ["1338d1c9-7c75-42ed-95f3-9eb1b6fc51d3"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (59762-0057-1)", "package_ndc": "59762-0057-1", "marketing_start_date": "20030117"}], "brand_name": "Alprazolam XR", "product_id": "59762-0057_70f0098e-50b5-4e61-b4e0-141a55d92267", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]"], "product_ndc": "59762-0057", "dea_schedule": "CIV", "generic_name": "alprazolam", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Alprazolam", "brand_name_suffix": "XR", "active_ingredients": [{"name": "ALPRAZOLAM", "strength": ".5 mg/1"}], "application_number": "NDA021434", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20030117", "listing_expiration_date": "20261231"}